The Company is committed to the research and development of new drugs and new medical technologies. Internally, we encourage and value innovation and invention; externally, we respect the intellectual property rights of others. To protect the Company's innovative R&D achievements, strengthen its competitive advantage, and generate revenue through intellectual property rights, this Intellectual Property Management has been formulated.

II. Patent Management

1. To protect the Company's innovative technologies, patent applications are subject to thorough evaluation prior to filing, with careful planning for international patent deployment. During the application process, procedures are strictly controlled to secure the most appropriate scope of patent rights. 
2. After patent approval, the relationship between the patents and products is continually reviewed to build a high-quality patent portfolio. 
3. The Company continuously monitors industry-related patent developments and conducts freedom to operate (FTO) analyses to manage potential risks. 
4. Through training or project discussions, the Company enhances employees' awareness of and skills in patent management. 

III. Trademark Management

1. To protect the Company's brand image, trademarks have been registered in major markets such as Taiwan, Japan, and China. 
2. In accordance with business development strategies, new trademark applications are filed in advance. 
3. The Company regularly reviews trademark usage and evaluates the cost-effectiveness of trademark maintenance. 

IV. Trade Secret Management 

1. The Company signs confidentiality agreements with all employees, specifying intellectual property ownership, confidentiality obligations, and non-compete clauses. 
2. Confidential data is inventoried, classified, graded, and labeled; storage, usage, and access controls are implemented according to confidentiality levels. 
3. The Company conducts periodic training and awareness programs on information security and confidentiality to strengthen employees' awareness of trade secret protection. 

V. Implementation

1. The Company reports intellectual property–related matters to the Board of Directors at least once a year
(Board report dated 2024/01/30)
2. The Company has achieved the following intellectual property results：
– Patents: A total of 26 patents have been granted
– Trademarks: A total of 29 domestic and international trademarks have been granted.